Patient Characteristics and Real-World Treatment of Very Elderly Patients with Nonvalvular Atrial Fibrillation in Japan: An Administrative Claims Database Study
A significant proportion of very elderly patients with NVAF in Japan were diagnosed with NVAF after the age of 80 years and were not receiving anticoagulation therapy, particularly with increasing age. Furthermore, warfarin use declined with age, and patients on DOACs frequently received reduced doses.
Authors
- Ako Ohsawa (ORCID: https://orcid.org/0009-0006-0855-2602)
- Jun Katada (ORCID: https://orcid.org/0000-0003-3588-3686)
Institutions
- Pfizer (Japan) (JP)
Publication Details
- Journal
- Cardiology and Therapy
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1007/s40119-024-00392-3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Pfizer Japan